Tight Glycemic Control by Artificial Pancreas

Kochi University

Status: Completed

Conditions: Pancreatic Neoplasm

Treatments: Device: Artificial Pancreas (STG-22)

Study type: Interventional

Funder types: Other

Identifiers

NCT00657995

TGC-AP-01

Details and patient eligibility

About

This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.

Full description

This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

Enrollment: 32 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

Exclusion criteria

• weight loss greater than 10% during the previous 6 months
• signs of distant metastasis
• respiratory, renal,or heart disease
• Patients provided written informed consent prior to enrollment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

32 participants in 1 patient group

2

Experimental group

Description:

Thirty patients who underwent pancreatic resection for pancreatic neoplasm were prospectively randomized. Perioperative blood glucose levels were continuously monitored using an artificial endocrine pancreas (STG-22). Glucose levels were controlled using either the sliding scale method or the artificial pancreas.

Treatment:

Device: Artificial Pancreas (STG-22)